Specimen oriented intraoperative margin assessment in oral cavity and oropharyngeal squamous cell carcinoma. 2021

P Horwich, and C MacKay, and M Bullock, and S M Taylor, and R Hart, and J Trites, and L Geldenhuys, and B Williams, and M H Rigby
Department of Surgery, Division of Otolaryngology - Head and Neck Surgery, Queen Elizabeth II Health Science Centre and Dalhousie University, 3rd Floor Dickson Building, VG Site, 5820 University Avenue, Halifax, Nova Scotia, B3H 2Y9, Canada. Peter.Horwich@dal.ca.

OBJECTIVE Evaluate the oncologic outcomes and cost analysis of transitioning to a specimen oriented intraoperative margin assessment protocol from a tumour bed sampling protocol in oral cavity (OCSCC) and oropharyngeal squamous cell carcinoma (OPSCC). METHODS Retrospective case series and subsequent prospective cohort study SETTING: Tertiary care academic teaching hospital SUBJECTS AND METHODS: Retrospective case series of all institutional T1-T2 OCSCC or OPSCC treated with primary surgery between January 1st 2009 - December 31st 2014. Kaplan-Meier survival estimates with log rank tests were used to compare patients based on final margin status. Cost analysis was performed for escalation of therapy due to positive final margins. Following introduction of a specimen derived margin protocol, successive prospective cohort study of T1-T4 OCSCC or OPSCC treated with primary surgery from January 1st 2017 - December 31st 2018. Analysis and comparison of both protocols included review of intraoperative margins, final pathology and treatment cost. RESULTS Analysis of our intra-operative tumour bed frozen section protocol revealed 15 of 116 (12.9%) patients had positive final pathology margins, resulting in post-operative escalation of therapy for 14/15 patients in the form of re-resection (7/14), radiation therapy (6/14) and chemoradiotherapy (1/14). One other patient with positive final margins received escalated therapy for additional negative prognostic factors. Recurrence free survival at 3 years was 88.4 and 50.7% for negative and positive final margins respectively (p = 0.048). Implementation of a specimen oriented frozen section protocol resulted in 1 of 111 patients (0.9%) having positive final pathology margins, a statistically significant decrease (p < 0.001). Utilizing our specimen oriented protocol, there was an absolute risk reduction for having a final positive margin of 12.0% and relative risk reduction of 93.0%. Estimated cost avoidance applying the specimen oriented protocol to our previous cohort was $412,052.812017 CAD. CONCLUSIONS Implementation of a specimen oriented intraoperative margin protocol provides a statistically significant decrease in final positive margins. This change in protocol leads to decreased patient morbidity by avoiding therapy escalation attributable only to positive margins, and avoids the economic costs of these treatments.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009062 Mouth Neoplasms Tumors or cancer of the MOUTH. Cancer of Mouth,Mouth Cancer,Oral Cancer,Oral Neoplasms,Cancer of the Mouth,Neoplasms, Mouth,Neoplasms, Oral,Cancer, Mouth,Cancer, Oral,Cancers, Mouth,Cancers, Oral,Mouth Cancers,Mouth Neoplasm,Neoplasm, Mouth,Neoplasm, Oral,Oral Cancers,Oral Neoplasm
D009674 Nova Scotia A province of eastern Canada, one of the Maritime Provinces with NEW BRUNSWICK; PRINCE EDWARD ISLAND; and sometimes NEWFOUNDLAND AND LABRADOR. Its capital is Halifax. The territory was granted in 1621 by James I to the Scotsman Sir William Alexander and was called Nova Scotia, the Latin for New Scotland. The territory had earlier belonged to the French, under the name of Acadia. (From Webster's New Geographical Dictionary, 1988, p871 & Room, Brewer's Dictionary of Names, 1992, p384)
D009959 Oropharyngeal Neoplasms Tumors or cancer of the OROPHARYNX. Cancer of Oropharnyx,Oropharyngeal Cancer,Cancer of the Oropharynx,Neoplasms, Oropharyngeal,Oropharynx Cancer,Oropharynx Neoplasms,Cancer, Oropharyngeal,Cancer, Oropharynx,Cancers, Oropharyngeal,Cancers, Oropharynx,Neoplasm, Oropharyngeal,Neoplasm, Oropharynx,Neoplasms, Oropharynx,Oropharnyx Cancer,Oropharnyx Cancers,Oropharyngeal Cancers,Oropharyngeal Neoplasm,Oropharynx Cancers,Oropharynx Neoplasm
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup

Related Publications

P Horwich, and C MacKay, and M Bullock, and S M Taylor, and R Hart, and J Trites, and L Geldenhuys, and B Williams, and M H Rigby
March 2017, Surgical pathology clinics,
P Horwich, and C MacKay, and M Bullock, and S M Taylor, and R Hart, and J Trites, and L Geldenhuys, and B Williams, and M H Rigby
November 2023, JAMA otolaryngology-- head & neck surgery,
P Horwich, and C MacKay, and M Bullock, and S M Taylor, and R Hart, and J Trites, and L Geldenhuys, and B Williams, and M H Rigby
January 2022, OTO open,
P Horwich, and C MacKay, and M Bullock, and S M Taylor, and R Hart, and J Trites, and L Geldenhuys, and B Williams, and M H Rigby
August 2013, Otolaryngologic clinics of North America,
P Horwich, and C MacKay, and M Bullock, and S M Taylor, and R Hart, and J Trites, and L Geldenhuys, and B Williams, and M H Rigby
February 2014, Cancer,
P Horwich, and C MacKay, and M Bullock, and S M Taylor, and R Hart, and J Trites, and L Geldenhuys, and B Williams, and M H Rigby
April 2024, The Laryngoscope,
P Horwich, and C MacKay, and M Bullock, and S M Taylor, and R Hart, and J Trites, and L Geldenhuys, and B Williams, and M H Rigby
January 2015, CA: a cancer journal for clinicians,
P Horwich, and C MacKay, and M Bullock, and S M Taylor, and R Hart, and J Trites, and L Geldenhuys, and B Williams, and M H Rigby
January 2019, Oral oncology,
P Horwich, and C MacKay, and M Bullock, and S M Taylor, and R Hart, and J Trites, and L Geldenhuys, and B Williams, and M H Rigby
December 2004, Cancer,
P Horwich, and C MacKay, and M Bullock, and S M Taylor, and R Hart, and J Trites, and L Geldenhuys, and B Williams, and M H Rigby
August 2017, Oral and maxillofacial surgery clinics of North America,
Copied contents to your clipboard!